Oncotarget

Research Papers:

Molecular architecture of the ErbB2 extracellular domain homodimer

Shi Hu _, Yuna Sun, Yanchun Meng, Xiaoze Wang, Weili Yang, Wenyan Fu, Huaizu Guo, Weizhu Qian, Sheng Hou, Bohua Li, Zihe Rao, Zhiyong Lou and Yajun Guo

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:1695-1706. https://doi.org/10.18632/oncotarget.2713

Metrics: PDF 2455 views  |   HTML 3000 views  |   ?  


Abstract

Shi Hu1,2,3,4,*, Yuna Sun2,3,*, Yanchun Meng5,6,7,*, Xiaoze Wang5, Weili Yang4,5, Wenyan Fu4, Huaizu Guo1,6, Weizhu Qian1,6, Sheng Hou1,4,6,7, Bohua Li1,4, Zihe Rao2,3, Zhiyong Lou3, Yajun Guo1,4,5,6,7

1International Joint Cancer Institute & Translational Medicine Research Institute, the Second Military Medical University, Shanghai, 200433, P.R. China

2National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing, 100101, P.R. China

3Laboratory of Structural Biology and MOE Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, 100084, P.R. China

4Cancer Center, Chinese PLA General Hospital & Chinese PLA Medical School, Beijing, 100853, P.R. China

5School of Medicine, Nankai University, Tianjin, 300071, P.R. China

6National Engineering Research Center for Antibody Medicine and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai, 201203, P.R. China

7School of Pharmacy, Liaocheng University, Liaocheng, Shandong, 252000, P.R. China

*These authors have contributed equally to this work

Correspondence to:

Yajun Guo, e-mail: yjguo_smmu@163.com

Zhiyong Lou, e-mail: louzy@xtal.tsinghua.edu.cn

Keywords: ErbB2, dimerization, signal transduction, crystal structure, Oncogene

Received: October 08, 2014     Accepted: November 08, 2014     Published: January 30, 2015

ABSTRACT

Human epidermal growth factor receptors (HERs or ErbBs) play crucial roles in numerous cellular processes. ErbB2 is a key member of ErbB family, and its overexpression is recognized as a frequent molecular abnormality. In cancer, this overexpression correlates with aggressive disease and poor patient outcomes. Dimer-dependent phosphorylation is a key event for the signal transduction of ErbBs. However, the molecular mechanism of the dimerization of ErbB2 remains elusive. In the present work, we report the homodimer architecture of the ErbB2 extracellular domain (ECD) which is unique compared with other dimer-models of ErbBs. The structure of the ErbB2 ECD homodimer represents a “back to head” interaction, in which a protruding β-hairpin arm in domain II of one ErbB2 protomer is inserted into a C-shaped pocket created by domains I–III of the adjacent ErbB2 protomer. This dimerized architecture and its impact on the phosphorylation of ErbB2 intracellular domain were further verified by a mutagenesis study. We also elucidated the different impacts of two clinically administered therapeutic antibodies, trastuzumab and pertuzumab, on ErbB2 dimerization. This information not only provides an understanding of the molecular mechanism of ErbBs dimerization but also elucidates ErbB2-targeted therapy at the molecular level.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2713